Subscribe to RSS - Daniel Greenleaf

Daniel Greenleaf

‘Disruptors’ put a dent in BioScrip’s earnings


DENVER – Company officials at BioScrip blamed a second straight quarter of net revenue declines on several “disrupters,” both expected and unexpected.

BioScrip restructures credit


DENVER – BioScrip has announced a plan to increase its liquidity.

Turnaround king?

Daniel Greenleaf rolls up his sleevs

Daniel Greenleaf is in a familiar position. The new president and CEO of BioScrip is tasked with turning around an underperforming home infusion company, which he did with both Coram and, more recently, with Home Solutions.

BioScrip ‘took its eye off the ball’


DENVER – With revenues at BioScrip sliding again in the third quarter, new President and CEO Daniel Greenleaf didn’t mince words on a recent earnings call.

In brief: Stakeholders keep eye on doc fix, CMS issues refunds


WASHINGTON – As this year’s congressional session winds down, HME stakeholders are eyeing the “doc-fix” bill as the best vehicle for H.R. 1717.

Former Apria exec moves to new post


DENVER – Daniel Greenleaf is now president and CEO of specialty-infusion company Home Solutions, the Denver Post reports.